BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

559 related articles for article (PubMed ID: 27745764)

  • 1. Factors Associated With Participation in an Emergency Department-Based Take-Home Naloxone Program for At-Risk Opioid Users.
    Kestler A; Buxton J; Meckling G; Giesler A; Lee M; Fuller K; Quian H; Marks D; Scheuermeyer F
    Ann Emerg Med; 2017 Mar; 69(3):340-346. PubMed ID: 27745764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient characteristics associated with being offered take home naloxone in a busy, urban emergency department: a retrospective chart review.
    O'Brien DC; Dabbs D; Dong K; Veugelers PJ; Hyshka E
    BMC Health Serv Res; 2019 Sep; 19(1):632. PubMed ID: 31488142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opioid education and nasal naloxone rescue kits in the emergency department.
    Dwyer K; Walley AY; Langlois BK; Mitchell PM; Nelson KP; Cromwell J; Bernstein E
    West J Emerg Med; 2015 May; 16(3):381-4. PubMed ID: 25987910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Yes, not now, or never: an analysis of reasons for refusing or accepting emergency department-based take-home naloxone.
    Kestler A; Giesler A; Buxton J; Meckling G; Lee M; Hunte G; Wilkins J; Marks D; Scheuermeyer F
    CJEM; 2019 Mar; 21(2):226-234. PubMed ID: 29789030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Awareness, Possession, and Use of Take-Home Naloxone Among Illicit Drug Users, Vancouver, British Columbia, 2014-2015.
    Nolan S; Buxton J; Dobrer S; Dong H; Hayashi K; Milloy MJ; Kerr T; Montaner J; Wood E
    Public Health Rep; 2017; 132(5):563-569. PubMed ID: 28750193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adoption and Utilization of an Emergency Department Naloxone Distribution and Peer Recovery Coach Consultation Program.
    Samuels EA; Baird J; Yang ES; Mello MJ
    Acad Emerg Med; 2019 Feb; 26(2):160-173. PubMed ID: 30074673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emergency department naloxone distribution: a Rhode Island department of health, recovery community, and emergency department partnership to reduce opioid overdose deaths.
    Samuels E
    R I Med J (2013); 2014 Oct; 97(10):38-9. PubMed ID: 25271659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Naloxone provision to emergency department patients recognized as high-risk for opioid use disorder.
    Lane BH; Lyons MS; Stolz U; Ancona RM; Ryan RJ; Freiermuth CE
    Am J Emerg Med; 2021 Feb; 40():173-176. PubMed ID: 33243535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overdose and take-home naloxone in emergency settings: A pilot study examining feasibility of delivering brief interventions addressing overdose prevention with 'take-home naloxone' in emergency departments.
    Black E; Monds LA; Chan B; Brett J; Hutton JE; Acheson L; Penm J; Harding S; Strumpman D; Demirkol A; Lintzeris N
    Emerg Med Australas; 2022 Aug; 34(4):509-518. PubMed ID: 35021268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Naloxone Use Among Emergency Department Patients with Opioid Overdose.
    Marco CA; Trautman W; Cook A; Mann D; Rasp J; Perkins O; Ballester M
    J Emerg Med; 2018 Jul; 55(1):64-70. PubMed ID: 29776702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rhode Island's Opioid Overdose Hospital Standards and Emergency Department Naloxone Distribution, Behavioral Counseling, and Referral to Treatment.
    Samuels EA; Wentz A; McCormick M; McDonald JV; Marshall BDL; Friedman C; Koziol J; Alexander-Scott NE
    Ann Emerg Med; 2021 Jul; 78(1):68-79. PubMed ID: 33865617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emergency department physicians' and pharmacists' perspectives on take-home naloxone.
    Holland TJ; Penm J; Dinh M; Aran S; Chaar B
    Drug Alcohol Rev; 2019 Feb; 38(2):169-176. PubMed ID: 30697852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Naloxone Administration in US Emergency Departments, 2000-2011.
    Frank JW; Levy C; Calcaterra SL; Hoppe JA; Binswanger IA
    J Med Toxicol; 2016 Jun; 12(2):148-56. PubMed ID: 26621354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Do electronic health record prompts increase take-home naloxone administration for emergency department patients after an opioid overdose?
    Marino R; Landau A; Lynch M; Callaway C; Suffoletto B
    Addiction; 2019 Sep; 114(9):1575-1581. PubMed ID: 31013394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Piloting a statewide emergency department take-home naloxone program: Improving the quality of care for patients at risk of opioid overdose.
    Dora-Laskey A; Kellenberg J; Dahlem CH; English E; Gonzalez Walker M; Brummett CM; Kocher KE
    Acad Emerg Med; 2022 Apr; 29(4):442-455. PubMed ID: 34962682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statewide Policy to Increase Provision of Take-Home Naloxone at Emergency Department Visits for Opioid Overdose, Rhode Island, 2018‒2019.
    Griffith J; Yorlets RR; Chambers LC; Davis CS; Wentz A; Beaudoin FL; Baird J; Samuels EA
    Am J Public Health; 2023 Apr; 113(4):372-377. PubMed ID: 36745856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acceptability of prison-based take-home naloxone programmes among a cohort of incarcerated men with a history of regular injecting drug use.
    Curtis M; Dietze P; Aitken C; Kirwan A; Kinner SA; Butler T; Stoové M
    Harm Reduct J; 2018 Sep; 15(1):48. PubMed ID: 30241532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics of Patients With Opioid Use Disorder Associated With Performing Overdose Reversals in the Community: An Opioid Treatment Program Analysis.
    Katzman JG; Greenberg NH; Takeda MY; Moya Balasch M
    J Addict Med; 2019; 13(2):131-138. PubMed ID: 30303890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a take-home naloxone program at an urban academic emergency department.
    Eswaran V; Allen KC; Cruz DS; Lank PM; McCarthy DM; Kim HS
    J Am Pharm Assoc (2003); 2020; 60(6):e324-e331. PubMed ID: 32690447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Findings and lessons learnt from implementing Australia's first health service based take-home naloxone program.
    Chronister KJ; Lintzeris N; Jackson A; Ivan M; Dietze PM; Lenton S; Kearley J; van Beek I
    Drug Alcohol Rev; 2018 May; 37(4):464-471. PubMed ID: 27071354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.